Sepsis in the elderly

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/978-2-8178-0287-9_19
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparison of dopamine and norepinephrine in the treatment of shock.

  2010cited by this paper
• Long-term cognitive impairment and functional disability among survivors of severe sepsis.

  2010cited by this paper
• Epinephrine: Is it really the black sheep of vasoactive agents?

  2010cited by this paper
• Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department*

  2010cited by this paper
• Adrenal insufficiency in the elderly: a nationwide study of hospitalizations in Taiwan.

  2010cited by this paper
• Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data

  2009cited by this paper
• Safety and efficacy of corticosteroids for the treatment of septic shock: A systematic review and meta-analysis.

  2009cited by this paper
• The epidemiology of, and risk factors for, mortality from severe sepsis and septic shock in a tertiary-care university hospital setting

  2009cited by this paper
• The aging of the immune system

  2009cited by this paper
• Corticosteroids in the treatment of severe sepsis and septic shock in adults: a systematic review.

  2009cited by this paper
• Epidemiology of Severe Sepsis in the Emergency Department and Difficulties in the Initial Assistance

  2008cited by this paper
• The compensatory anti-inflammatory response syndrome (CARS) in critically ill patients.

  2008cited by this paper
• Epidemiology of myocardial infarction.

  2007cited by this paper
• Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008

  2007cited by this paper
• [Clinical evaluation of execution of early goal directed therapy in septic shock].

  2007cited by this paper
• Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans.

  2007cited by this paper
• Protein C concentrations in severe sepsis: an early directional change in plasma levels predicts outcome

  2006cited by this paper
• Regulatory dendritic cells act as regulators of acute lethal systemic inflammatory response.

  2006cited by this paper
• Decrease in circulating dendritic cells predicts fatal outcome in septic shock

  2006cited by this paper
• CD27(+) (memory) B cell decrease and apoptosis-resistant CD27(-) (naive) B cell increase in aged humans: implications for age-related peripheral B cell developmental disturbances.

  2005cited by this paper
• Early changes in organ function predict eventual survival in severe sepsis*

  2005cited by this paper
• Corticosteroids for septic shock.

  2004cited by this paper
• Indicators of potentially drug-resistant bacteria in severe nursing home-acquired pneumonia.

  2004cited by this paper
• Recombinant human activated protein C in the treatment of severe sepsis: An evidence-based review

  2004cited by this paper
• Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock

  2004cited by this paper
• Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia.

  2004cited by this paper
• [Aging and immunity].

  2003cited by this paper
• Quality indicators for end-of-life care in the intensive care unit*

  2003cited by this paper
• Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis.

  2003cited by this paper
• The epidemiology of sepsis in the United States from 1979 through 2000.

  2003cited by this paper
• Drotrecogin alfa (activated) treatment of older patients with severe sepsis.

  2003cited by this paper
• Age‐related depression of FDC accessory functions and CD21 ligand‐mediated repair of co‐stimulation

  2002cited by this paper
• Sepsis in Older Patients: An Emerging Concern in Critical Care

  2002cited by this paper
• Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock.

  2002cited by this paper
• Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care

  2001cited by this paper
• Efficacy and safety of recombinant human activated protein C for severe sepsis.

  2001cited by this paper
• Early Goal-Directed Therapy in the Treatment of Severe Sepsis and Septic Shock

  2001cited by this paper
• Source control in the management of sepsis

  2001cited by this paper
• Epidemiology of sepsis: An update

  2001cited by this paper
• Insights About Dying from the SUPPORT Project

  2000cited by this paper
• Prognostic value of cortisol response in septic shock

  2000cited by this paper
• Insights about dying from the SUPPORT project. The Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments.

  2000cited by this paper
• The Effect of Age on the B-Cell Repertoire

  2000cited by this paper
• Inflamm‐aging: An Evolutionary Perspective on Immunosenescence

  2000cited by this paper
• Human immunosenescence: the prevailing of innate immunity, the failing of clonotypic immunity, and the filling of immunological space.

  2000cited by this paper
• Protein C levels as a prognostic indicator of outcome in sepsis and related diseases

  2000cited by this paper
• Clinical relevance of age-related immune dysfunction.

  2000cited by this paper
• Immunosenescence: impact in the young as well as the old?

  1999cited by this paper
• A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group.

  1999cited by this paper
• Activation of the tissue factor pathway of blood coagulation during prolonged hyperglycemia in young healthy men.

  1999cited by this paper
• Prolonged overexpansion of extracellular water in elderly patients with sepsis.

  1998cited by this paper
• Natural killer cells in the late decades of human life.

  1997cited by this paper
• The clinical evaluation of new drugs for sepsis. A prospective study design based on survival analysis.

  1993cited by this paper
• The aging process: major risk factor for disease and death.

  1991cited by this paper
• A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock.

  1987cited by this paper

• Sepsis at ICU admission does not decrease 30-day survival in very old patients: a post-hoc analysis of the VIP1 multinational cohort study

  2020cites this paper